Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence.

Item

http://www.wikidata.org/entity/Q43217399

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@en

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@nl

type

Item

label

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@en

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@nl

prefLabel

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@en

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@nl

P1476

Risk assessment in hypertrophi ...... ered by insufficient evidence.

@en

P2093

Alison Rachel Muir

http://www.w3.org/2001/XMLSchema#string

Pascal P McKeown

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration.

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.

A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patie

Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.

Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy.

Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience.

Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

P304

511-513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/HEARTJNL-2012-303363

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235397197

http://www.w3.org/2001/XMLSchema#string

P698

23376948

http://www.w3.org/2001/XMLSchema#string

P932

3607114

http://www.w3.org/2001/XMLSchema#string